A Phase 1/2, Open-Label, Multi-Center, Dose Escalation and Expansion Study of KB707 in Subjects with Locally Advanced or Metastatic Solid Tumor Malignancies
| Protocol No. | CTO-KB707-01 | Scope | National |
|---|---|---|---|
| Principal Investigator | Mateusz Opyrchal | Treatment Type | Treatment |
| Age Group | Adult | Phase | Phase I |
